DOCS logo

Dr. Martens plc Stock Price

LSE:DOCS Community·UK£871.7m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 33 Fair Values set on narratives written by author
Create a narrative

DOCS Share Price Performance

UK£0.92
0.36 (64.81%)
35.1% undervalued intrinsic discount
UK£1.41
Fair Value
UK£0.92
0.36 (64.81%)
19.7% undervalued intrinsic discount
UK£1.14
Fair Value
Price UK£0.92
AnalystHighTarget UK£1.14
AnalystConsensusTarget UK£1.00
AnalystLowTarget UK£0.75

DOCS Community Narratives

AnalystHighTarget·
Fair Value UK£1.41 35.1% undervalued intrinsic discount

Asian DTC Markets And Digital Retail Will Expand Global Reach

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value UK£1 8.5% undervalued intrinsic discount

Cost Savings Ahead Of Schedule Will Improve Profitability By FY '26

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
AnalystLowTarget·
Fair Value UK£0.75 22.1% overvalued intrinsic discount

High Valuations Will Suffer Rising Supply Costs And Consumer Shifts

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent DOCS News & Updates

Returns On Capital Signal Tricky Times Ahead For Dr. Martens (LON:DOCS)

Aug 26
Returns On Capital Signal Tricky Times Ahead For Dr. Martens (LON:DOCS)

Is Dr. Martens plc (LON:DOCS) Trading At A 29% Discount?

Aug 05
Is Dr. Martens plc (LON:DOCS) Trading At A 29% Discount?

Dr. Martens (LON:DOCS) Has Announced That It Will Be Increasing Its Dividend To £0.017

Jun 18
Dr. Martens (LON:DOCS) Has Announced That It Will Be Increasing Its Dividend To £0.017

Some Investors May Be Willing To Look Past Dr. Martens' (LON:DOCS) Soft Earnings

Jun 15
Some Investors May Be Willing To Look Past Dr. Martens' (LON:DOCS) Soft Earnings

Dr. Martens plc Key Details

UK£787.6m

Revenue

UK£275.9m

Cost of Revenue

UK£511.7m

Gross Profit

UK£507.2m

Other Expenses

UK£4.5m

Earnings

Last Reported Earnings
Mar 30, 2025
Next Reporting Earnings
Nov 20, 2025
Earnings per share (EPS)
0.0047
Gross Margin
64.97%
Net Profit Margin
0.57%
Debt/Equity Ratio
67.9%

Dr. Martens plc Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

3 Risks
2 Rewards
View Full Analysis

About DOCS

Founded
1945
Employees
2348
CEO
Onyeije Nwokorie
WebsiteView website
www.drmartensplc.com

Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Market Insight

Header cover image

✨Rare Earths: Tiny Market, Outsized Influence

Richard Bowman avatarRichard Bowman
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Last Week
⚡ Utilities: Defensive Dividends Meet the AI Power Surge

⚡ Utilities: Defensive Dividends Meet the AI Power Surge

U.K. Market Performance

  • 7 Days: 1.2%
  • 3 Months: 6.8%
  • 1 Year: 14.6%
  • Year to Date: 14.3%
Over the last 7 days, the market has risen 1.2%, driven by gains of 9.0% in the Healthcare sector. In the last year, the market has climbed 15%. Looking forward, earnings are forecast to grow by 14% annually. Market details ›